Hear.com Horizon Go IX vs Signia Pure C&G BCT IX
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.
Choice

Hear.com Horizon Go IX
The Hear.com Horizon Go IX is a premium prescription behind-the-ear hearing aid released in 2024, listed at $6,500. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.4/5, ranking #17 among 36 prescription hearing aids tested. This device demonstrates particular strength in speech clarity. Speech in quiet scored a strong 4.0/5, which is +0.72 points above the category average. Speech in noise performance also exceeded the category average by +0.61 points, though at 2.6/5 the absolute score remains mixed—meaning it handles challenging listening environments better than many competitors but still has room for improvement in demanding situations. The most notable limitation is own-voice comfort, scoring 1.8/5—a low result that falls 0.95 points below the category average. Users sensitive to how their own voice sounds may find this particularly noticeable. Feedback handling is strong in absolute terms at 4.4/5, though it sits slightly below the category average by 0.31 points. Music streaming performance is mixed at 2.7/5, essentially matching the category average. At this price point, the Horizon Go IX faces stiff competition. Same-price alternatives like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) deliver higher overall sound performance. Budget-conscious shoppers might also consider options like the Rexton Reach R-Li T80 at Costco, which achieves a higher score at a lower price. The Horizon Go IX is best suited for those prioritizing speech clarity who can accept the own-voice trade-off and prefer the hear.com service model.
Choice

Signia Pure C&G BCT IX
The Signia Pure C&G BCT IX is a premium prescription behind-the-ear hearing aid released in 2025, priced at $3,398. In our lab testing, it earned an A grade with a SoundScore of 4.4/5, placing it in the top 39% of the 36 prescription hearing aids we've tested. This device shows notable strengths in speech clarity and own-voice comfort. Speech in quiet scored 3.8/5, which is 0.47 points above the category average—a solid result for everyday conversations. Speech in noise measured 2.5/5, above the category average by 0.58 points, though only mixed in absolute terms, meaning challenging listening environments may still present difficulty. Own-voice comfort is a standout at 3.8/5, a full 1.05 points above average, suggesting reduced occlusion effects that many wearers find bothersome. Feedback handling scored 4.2/5—strong in absolute terms, though 0.51 points below the category average of 4.71/5. Music streaming at 2.7/5 is essentially on par with category average. The device features rechargeable batteries, iPhone and Android streaming, and hands-free functionality. Consumers shopping in this premium price tier should note that several alternatives offer higher overall scores, including the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5). For those prioritizing own-voice comfort and solid speech performance in quieter settings, the Pure C&G BCT IX delivers, but buyers seeking top-tier noise performance may want to compare options.
We independently review each item we recommend and appreciate your trust and support. When you buy through our links, we may earn a commission. Learn More.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit